Rubella antibody level and immunity strategy among Chinese residents and Burmese entering China in border regions of Yunnan province: a cross-sectional survey
-
摘要:
目的 调查云南省边境地区健康人群风疹抗体水平,评估免疫效果,为边境防控风疹工作提供科学依据。 方法 采用多阶段随机抽样方法,于2018年抽取云南省3个边境县9个乡(镇)27个村(居)委会共891名8月龄以上常住居民,采用医院便利抽样方法抽取891名缅籍入境人群进行问卷调查并采集血标本,采用酶联免疫吸附试验(ELISA)测定风疹IgG抗体,结果录入数据库,利用SPSS 21软件进行统计分析。 结果 云南省常住居民风疹抗体阳性率为79.35 %(95 % CI = 72.03 %~84.94 %),抗体几何平均浓度为31.37 IU/mL。缅甸籍入境人群风疹抗体阳性率为84.40 %(95 % CI = 79.98 %~88.97 %),抗体几何平均浓度为33.00 IU/mL,不同国籍间人群风疹抗体阳性率和抗体几何平均浓度差异均有统计学意义(χ2 = 6.72,P < 0.05;U = 2.38,P < 0.05)。常住居民3~19岁人群风疹抗体阳性率较低,3~29岁人群风疹抗体几何平均浓度较低,不同年龄组人群风疹抗体水平差异有统计学意义(χ2 = 25.91,P < 0.05;H = 21.96,P < 0.05)。常住居民育龄期妇女风疹抗体阳性率为82.14 %,风疹抗体几何平均浓度为34.30 IU/mL,风疹抗体几何平均浓度与年龄呈负相关。 结论 云南省中缅边境地区健康人群风疹抗体水平较低,需警惕入境风疹感染者作为传染源将风疹传入中国并造成流行;3~29岁常住居民风疹易感性较高,适时增加育龄妇女加强免疫,可降低先天性风疹综合症发生风险。 Abstract:Objective To examine rubella antibody level and the effect of immunization among healthy Chinese residents and Burmese entering China in border regions of Yunnan province for providing evidences to rubella prevention and control in the populations. Methods During 2018 in Yunnan province, we conducted a study including questionnaire survey and blood specimen collection. The participants of the study were 891 residents aged elder than 8 months recruited with multistage random sampling in 27 villages/towns of 3 counties in border regions and 981 people recruited among Burmese entering China for seeking medical service at hospitals in the regions with convenient sampling. The collected blood specimens were detected for rubella immunoglobulin G (IgG) antibody with enzyme-linked immunosorbent assay (ELISA). SPSS 21 software was adopted in data process and analysis. Results Between the Chinese residents and the Burmese entering China, there were significant differences in positive rate of rubella antibody (79.35% [95% confidence interval: 72.03%, 84.94%] vs. 84.40% [95% confidence interval: 79.98%, 88.97%], χ2 = 6.72, P < 0.05) and geometric mean concentration of IgG (31.37 IU/ml vs. 33.00 IU/ml, U = 2.38; P < 0.05) of rubella. The rubella antibody level differed significantly among the Chinese residents of various age groups, with a lower antibody positive rate in the residents aged 3 – 19 years (χ2 = 25.91, P < 0.05) and a lower geometric mean concentration of IgG in the residents aged 3 – 29 years (H = 21.96, P < 0.05). For the childbearing women in the Chinese residents, the rubella antibody positive rate was 82.14% and the geometric mean concentration of IgG was 34.30 IU/ml and reversely correlated with the age of the women. Conclusion The blood rubella antibody is at a relatively low level among healthy populations in China-Myanmar border region of Yunnan province, suggesting that there is a risk of rubella epidemic in Chinese residents due to the infected Burmese entering China, especially in the residents aged 3 – 29 years and in the childbearing women. -
Key words:
- rubella /
- antibody /
- vaccine /
- immune effect
1) (袁书益为本文并列第一作者) -
表 1 云南省边境地区不同年龄人群风疹抗体水平比较
年龄 缅籍入境人群 本地常住居民 调查人数 构成比(%) 阳性率(%) GMC(IU/mL) 调查人数 构成比(%) 阳性率(%) GMC(IU/mL) 月龄(岁) 8~17 136 15.26 79.41 20.08 135 15.15 72.59 16.18 18~35 109 12.23 86.24 32.83 108 12.12 89.81 60.65 3~6 108 12.12 77.78 24.05 108 12.12 74.07 29.15 7~14 107 12.01 94.39 40.79 108 12.12 79.63 33.76 15~19 48 5.39 87.50 27.51 60 6.73 73.33 39.24 20~29 108 12.12 84.26 36.69 122 13.69 85.79 25.66 30~39 122 13.69 81.97 38.12 110 12.35 87.27 40.11 40~49 99 11.11 90.91 54.73 96 10.77 80.21 28.99 ≥ 50 54 6.06 77.78 39.20 44 4.94 63.64 39.12 合计 891 99.99 84.40 33.00 891 100.00 79.35 31.37 表 2 云南省边境地区育龄期妇女风疹抗体水平
年龄组(岁) 调查人数 构成比(%) 阳性率(%) GMC(IU/mL) 15~19 32 14.29 75.00 50.66 20~29 80 35.71 86.25 34.57 30~39 59 26.34 84.75 32.65 40~49 53 23.66 77.36 28.29 合计 224 100.00 82.14 34.30 表 3 不同免疫史风疹抗体水平比较
免疫史(剂次) 调查人数 构成比(%) 阳性率(%) GMC(IU/mL) 0 396 44.44 77.02 27.99 1 170 19.08 79.41 28.67 2 277 31.09 81.23 38.84 ≥ 3 48 5.39 87.50 32.15 合计 891 100.00 79.35 31.37 表 4 不同接种年限人群风疹抗体水平比较
接种年限(年) 调查人数 构成比(%) 阳性率(%) GMC(IU/mL) < 1 293 59.19 84.64 37.46 1~2 69 13.94 81.16 37.38 3~4 52 10.51 69.23 20.97 ≥ 5 81 16.36 76.54 32.13 合计 495 100.00 81.21 34.36 -
[1] 云南省人民政府. 云南概况[EB/OL]. [2020 – 09 – 29]. http://www.yn.gov.cn/yngk/. [2] Word Health Organization. WHO vaccine-preventable diseases: monitoring system. 2020 global summary[EB/OL]. [2020-09-29]. https://apps.who.int/immunization_monitoring/globalsummary. [3] 卫生部. WS 297 — 2008风疹诊断标准[S]. 北京: 人民卫生出版社, 2009. [4] 马静, 罗会明, 郝利新, 等. 中国2005 — 2011年风疹流行病学特征分析[J]. 中国疫苗和免疫, 2012, 18(6): 500 – 503, 540. [5] 余文, 丁峥嵘, 李立群, 等. 云南省2005 — 2013年风疹流行特征分析[J]. 中国疫苗和免疫, 2015, 21(5): 524 – 528, 542. [6] 张丽文, 朱宗龙, 苑新海, 等. 北京市昌平区6岁儿童加强接种前后麻疹、流行性腮腺炎和风疹抗体水平监测分析[J]. 疾病监测, 2018, 33(1): 63 – 66. doi: 10.3784/j.issn.1003-9961.2018.01.015 [7] 吕宛玉, 史鲁斌, 王燕, 等. 河南省2016年健康人群麻疹、风疹、流行性腮腺炎抗体水平监测[J]. 中国疫苗和免疫, 2017, 23(4): 393 – 396, 418. [8] 龚欢, 张斌, 陈曦, 等. 2016年成都市成华区健康人群麻疹风疹抗体水平监测结果分析[J]. 预防医学情报杂志, 2018, 34(5): 660 – 663. [9] 蓝羲, 魏小庆, 周晓莉, 等. 2015年攀枝花市健康人群风疹抗体阳性率监测分析[J]. 预防医学情报杂志, 2018, 34(2): 169 – 172. [10] 刘艳, 许玉洋, 张学潮, 等. 2016 — 2018年杭州市健康人群风疹IgG抗体水平调查[J]. 中国疫苗和免疫, 2020, 26(5): 517 – 520. [11] 王庆, 王兆华, 史淑芬. 2012年北京市西城区健康人群风疹抗体水平调查及疫苗免疫效果分析[J]. 实用预防医学, 2018, 25(4): 455 – 458. doi: 10.3969/j.issn.1006-3110.2018.04.019
计量
- 文章访问数: 811
- HTML全文浏览量: 208
- PDF下载量: 20
- 被引次数: 0